MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 53 filers reported holding MENLO THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $283,000 | -55.0% | 105,500 | -22.1% | 0.01% | -25.0% |
Q4 2019 | $629,000 | +5.5% | 135,500 | +1.8% | 0.01% | 0.0% |
Q3 2019 | $596,000 | -24.5% | 133,100 | +1.1% | 0.01% | -20.0% |
Q2 2019 | $789,000 | -23.7% | 131,700 | 0.0% | 0.01% | -23.1% |
Q1 2019 | $1,034,000 | +100.8% | 131,700 | +5.4% | 0.01% | +85.7% |
Q4 2018 | $515,000 | -58.1% | 124,900 | 0.0% | 0.01% | -41.7% |
Q3 2018 | $1,230,000 | – | 124,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
venBio Partners L.P. | 1,461,552 | $11,868,000 | 12.24% |
Vivo Capital, LLC | 4,011,236 | $32,571,000 | 4.20% |
DAFNA Capital Management LLC | 312,000 | $2,533,000 | 1.19% |
Novo Holdings A/S | 1,436,313 | $11,663,000 | 1.17% |
Perceptive Advisors | 1,241,287 | $10,079,000 | 0.26% |
Rock Springs Capital Management LP | 330,000 | $2,680,000 | 0.10% |
Baker Brothers Advisors | 700,000 | $5,684,000 | 0.04% |
Schonfeld Strategic Advisors LLC | 50,000 | $406,000 | 0.02% |
A.R.T. Advisors, LLC | 31,703 | $257,000 | 0.01% |
JANUS HENDERSON GROUP PLC | 2,036,111 | $16,533,000 | 0.01% |